Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 44

Cited In for PubMed (Select 11113299)

1.

Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods.

Barth C, Villringer A, Sacher J.

Front Neurosci. 2015 Feb 20;9:37. doi: 10.3389/fnins.2015.00037. eCollection 2015. Review.

2.

Functional and molecular neuroimaging of menopause and hormone replacement therapy.

Comasco E, Frokjaer VG, Sundstr├Âm-Poromaa I.

Front Neurosci. 2014 Dec 8;8:388. doi: 10.3389/fnins.2014.00388. eCollection 2014. Review.

3.

Effects of hormone therapy on cognition and mood.

Fischer B, Gleason C, Asthana S.

Fertil Steril. 2014 Apr;101(4):898-904. doi: 10.1016/j.fertnstert.2014.02.025. Review.

4.

Oophorectomy, estrogen, and dementia: a 2014 update.

Rocca WA, Grossardt BR, Shuster LT.

Mol Cell Endocrinol. 2014 May 25;389(1-2):7-12. doi: 10.1016/j.mce.2014.01.020. Epub 2014 Feb 5. Review.

5.

Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.

O'Brien J, Jackson JW, Grodstein F, Blacker D, Weuve J.

Epidemiol Rev. 2014;36:83-103. doi: 10.1093/epirev/mxt008. Epub 2013 Sep 15. Review.

6.

Estrogen: a master regulator of bioenergetic systems in the brain and body.

Rettberg JR, Yao J, Brinton RD.

Front Neuroendocrinol. 2014 Jan;35(1):8-30. doi: 10.1016/j.yfrne.2013.08.001. Epub 2013 Aug 29. Review.

7.

Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by ╬▓ Amyloid.

Chang PK, Boridy S, McKinney RA, Maysinger D.

J Aging Res. 2013;2013:538979. doi: 10.1155/2013/538979. Epub 2013 Jul 17.

8.

Estrogen signaling and the aging brain: context-dependent considerations for postmenopausal hormone therapy.

Mott NN, Pak TR.

ISRN Endocrinol. 2013 Jul 7;2013:814690. doi: 10.1155/2013/814690. Print 2013.

9.

Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.

Henderson VW.

J Steroid Biochem Mol Biol. 2014 Jul;142:99-106. doi: 10.1016/j.jsbmb.2013.05.010. Epub 2013 May 28. Review.

10.

Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.

Maki PM.

Menopause. 2013 Jun;20(6):695-709. doi: 10.1097/GME.0b013e3182960cf8. Review.

11.

Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.

Miller VM, Garovic VD, Kantarci K, Barnes JN, Jayachandran M, Mielke MM, Joyner MJ, Shuster LT, Rocca WA.

Biol Sex Differ. 2013 Mar 28;4(1):6. doi: 10.1186/2042-6410-4-6.

12.

Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study.

Shao H, Breitner JC, Whitmer RA, Wang J, Hayden K, Wengreen H, Corcoran C, Tschanz J, Norton M, Munger R, Welsh-Bohmer K, Zandi PP; Cache County Investigators.

Neurology. 2012 Oct 30;79(18):1846-52. doi: 10.1212/WNL.0b013e318271f823. Epub 2012 Oct 24.

13.

Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on.

Maki PM, Henderson VW.

Climacteric. 2012 Jun;15(3):256-62. doi: 10.3109/13697137.2012.660613. Review.

14.

Continuous estrone treatment impairs spatial memory and does not impact number of basal forebrain cholinergic neurons in the surgically menopausal middle-aged rat.

Engler-Chiurazzi EB, Talboom JS, Braden BB, Tsang CW, Mennenga S, Andrews M, Demers LM, Bimonte-Nelson HA.

Horm Behav. 2012 Jun;62(1):1-9. doi: 10.1016/j.yhbeh.2012.04.004. Epub 2012 Apr 13.

15.

Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?

Gleason CE, Dowling NM, Friedman E, Wharton W, Asthana S.

Menopause. 2012 May;19(5):524-33. doi: 10.1097/gme.0b013e318238ff2c.

16.

Sex hormones, aging, and Alzheimer's disease.

Barron AM, Pike CJ.

Front Biosci (Elite Ed). 2012 Jan 1;4:976-97. Review.

17.

Estrogen neuroprotection and the critical period hypothesis.

Scott E, Zhang QG, Wang R, Vadlamudi R, Brann D.

Front Neuroendocrinol. 2012 Jan;33(1):85-104. doi: 10.1016/j.yfrne.2011.10.001. Epub 2011 Nov 4. Review.

18.

Investigational drugs for the treatment of AD: what can we learn from negative trials?

Jacobson SA, Sabbagh MN.

Alzheimers Res Ther. 2011 Apr 15;3(2):14. doi: 10.1186/alzrt73.

19.

Estradiol alters Fos-immunoreactivity in the hippocampus and dorsal striatum during place and response learning in middle-aged but not young adult female rats.

Pleil KE, Glenn MJ, Williams CL.

Endocrinology. 2011 Mar;152(3):946-56. doi: 10.1210/en.2010-0715. Epub 2011 Feb 1.

20.

Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity.

Rocca WA, Grossardt BR, Shuster LT.

Brain Res. 2011 Mar 16;1379:188-98. doi: 10.1016/j.brainres.2010.10.031. Epub 2010 Oct 18. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk